STATE – Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.
| Sr. No. | Product Name | Batch No. | Exp. Date |
| 1 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20045 | Nov.2023 |
| 2 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20055 | Nov.2023 |
| 3 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20056 | Nov.2023 |
| 4 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20057 | Nov.2023 |
| 5 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20059 | Nov.2023 |
| 6 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20072 | Nov.2023 |
